Kenneth Allen Myszkowski
Insider Reports History
- Location
- Pasadena, CA
- Signature
- /s/Kenneth Myszkowski
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Kenneth Allen Myszkowski:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Chief Financial Officer | Common Stock | 455,433 | $8,967,476 | $19.69 | 07 Jan 2025 | Direct |
Insider Reports Filed by Kenneth Allen Myszkowski
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 04 Jan 2025 | 5 | -$893,095 | 4 | Chief Financial Officer | 07 Jan 2025, 21:27 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 06 Mar 2024 | 1 | -$1,407,600 | 4 | Chief Financial Officer | 08 Mar 2024, 17:54 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 04 Jan 2024 | 4 | -$567,910 | 4 | Chief Financial Officer | 08 Jan 2024, 17:16 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 27 Jun 2023 | 1 | -$543,000 | 4 | Chief Financial Officer | 29 Jun 2023, 18:41 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 04 Jan 2023 | 1 | $0 | 4 | Chief Financial Officer | 05 Jan 2023, 18:14 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 29 Dec 2022 | 1 | -$1,225,000 | 4 | Chief Financial Officer | 30 Dec 2022, 16:12 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 30 Sep 2022 | 1 | $0 | 5 | Chief Financial Officer | 30 Sep 2022, 17:32 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 05 Jan 2022 | 4 | -$2,467,941 | 4 | Chief Financial Officer | 06 Jan 2022, 19:58 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 01 Jan 2022 | 1 | $0 | 4 | Chief Financial Officer | 04 Jan 2022, 20:25 |